Table 5 Pathways enriched in the high-risk group according to gene set enrichment analysis (GSEA)

KEGG_PRIMARY_IMMUNODEFICIENCY

0

0.121

Tags = 49%, list = 18%, signal = 59%

KEGG_OLFACTORY_TRANSDUCTION

0

0.341

Tags = 57%, list = 46%, signal = 104%

KEGG_ALLOGRAFT_REJECTION

0.019523

0.668

Tags = 31%, list = 16%, signal = 38%

KEGG_AUTOIMMUNE_THYROID_DISEASE

0.00463

0.685

Tags = 72%, list = 49%, signal = 141%

KEGG_GRAFT_VERSUS_HOST_DISEASE

0.011876

0.712

Tags = 27%, list = 16%, signal = 32%

KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION

0.01171

0.784

Tags = 37%, list = 23%, signal = 48%

KEGG_TASTE_TRANSDUCTION

0.065789

0.973

Tags = 44%, list = 22%, signal = 57%

KEGG_ASTHMA

0.073333

0.976

Tags = 25%, list = 15%, signal = 29%

KEGG_TYPE_I_DIABETES_MELLITUS

0.139326

1

Tags = 29%, list = 16%, signal = 35%

KEGG_ALPHA_LINOLENIC_ACID_METABOLISM

0.159751

1

Tags = 42%, list = 12%, signal = 48%

KEGG_LINOLEIC_ACID_METABOLISM

0.193059

1

Tags = 31%, list = 12%, signal = 35%

KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS

0.184697

1

Tags = 50%, list = 40%, signal = 84%

KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION

0.114391

1

Tags = 28%, list = 20%, signal = 35%

KEGG_HEMATOPOIETIC_CELL_LINEAGE

0.667494

1

Tags = 20%, list = 15%, signal = 24%